Liq­uidia wins ap­proval for in­haled hy­per­ten­sion drug in two set­tings, fur­ther­ing ri­val­ry with Unit­ed Ther­a­peu­tics

The FDA ap­proved Liq­uidia’s tre­pros­tinil pro­gram for two re­lat­ed kinds of high blood pres­sure, turn­ing up the heat on ri­val Unit­ed Ther­a­peu­tics and its Ty­va­so …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER